| Previous Close | 227.75 |
| Open | 227.99 |
| Bid | 224.65 x 1300 |
| Ask | 227.10 x 800 |
| Day's Range | 224.56 - 228.61 |
| 52 Week Range | 198.64 - 258.45 |
| Volume | |
| Avg. Volume | 2,637,392 |
| Market Cap | 121.413B |
| Beta (5Y Monthly) | 0.56 |
| PE Ratio (TTM) | 19.30 |
| EPS (TTM) | 11.76 |
| Earnings Date | Oct 31, 2022 - Nov 04, 2022 |
| Forward Dividend & Yield | 7.76 (3.41%) |
| Ex-Dividend Date | Aug 17, 2022 |
| 1y Target Est | 253.12 |
If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...
AstraZeneca's (AZN) Tezspire is the only biologic medicine approved in Europe to treat severe asthma with no phenotype limitation and irrespective of biomarker levels.
Amgen (AMGN) closed at $224.46 in the latest trading session, marking a -1.43% move from the prior day.